Pharmaceutical compounding company Fagron (EBR:FAGR) plans to combine with Humco and its portfolio of drug-delivery technology in a deal valued up to $70 million, the companies announced today. According to the agreement, Humco chairman & CEO Gregory Pulido will become executive chairman while Andrew Pulido, Humco’s president of global pharmaceuticals, will assume the role of president. “I […]